Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transplantation with blood stem cells.

A R Zander1, J Lyding, S Bielack

  • 1Department of Hematology-Oncology, Universitätskrankenhaus Eppendorf, Hamburg, FRG.

Blood Cells
|January 1, 1991
PubMed
Summary

Peripheral blood stem cell transplantation (PBSCT) provides a faster recovery alternative to autologous bone marrow transplants (A-BMT). While PBSCT shows promise, its advantage in disease control for malignant diseases remains unproven.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An assessment of the attitudes, knowledge, and education regarding the health care needs of LGBTQ patients with cancer: results of an ESMO/SIOPE global survey.

ESMO open·2024
Same author

Cancer burden in adolescents and young adults in Europe.

ESMO open·2023
Same author

Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>☆</sup>.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts.

ESMO open·2021

Area of Science:

  • Hematology
  • Oncology
  • Transplantation Medicine

Background:

  • Peripheral blood stem cell transplantation (PBSCT) is explored as an alternative to autologous bone marrow transplants (A-BMT), particularly for cancers with bone marrow involvement.
  • Hematopoietic precursors, including potentially pluripotent stem cells, circulate in peripheral blood, enabling engraftment after transplantation.
  • Mobilization of these stem cells is enhanced post-chemotherapy and can be stimulated by cytokines or polyanionic substances.

Purpose of the Study:

  • To evaluate the efficacy and outcomes of peripheral blood stem cell transplantation (PBSCT) compared to autologous bone marrow transplants (A-BMT).
  • To assess the potential advantages of PBSCT in terms of patient recovery and disease control in malignant conditions.

Main Methods:

  • Review of clinical trials involving peripheral blood stem cell transplantation (PBSCT) in patients with hematological and nonhematological malignancies.
  • Comparison of engraftment and recovery times between PBSCT and autologous bone marrow transplants (A-BMT).
  • Analysis of stem cell mobilization techniques utilizing chemotherapy, cytokines, and polyanionic substances for leukapheresis.

Main Results:

  • Peripheral blood stem cell transplantation (PBSCT) demonstrated generally more rapid patient recovery compared to autologous bone marrow transplants (A-BMT).
  • Successful engraftment and sustained trilineage hematopoiesis were observed in patients undergoing PBSCT.
  • Stem cell mobilization strategies effectively increased circulating hematopoietic precursors for optimized harvesting.

Conclusions:

  • Peripheral blood stem cell transplantation (PBSCT) offers a viable alternative to autologous bone marrow transplants (A-BMT) with accelerated recovery.
  • Despite faster recovery, the anticipated benefit of improved disease control with PBSCT has not yet been conclusively demonstrated in clinical trials.

Related Experiment Videos